ArticleFrontiers in oncology2024
Intramedullary schwannoma of conus medullaris with syringomyelia: a case report and literature review.
Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intramedullary schwannomas in the conus medullaris are very rare and are usually not associated with syringomyelia. We report a unique case of intramedullary schwannoma in the conus medullaris with long-segment syringomyelia. The patient was a 60-year-old male, initially presenting with left dorsalgia, subsequently developing weakness in the right lower extremity. As the symptoms progressed, the patient exhibited ataxia in gait, accompanied by sphincter insufficiency and voiding dysfunction. Lumbar MRI revealed the presence of two tumors at the L3 and T11-L1 levels, accompanied by syringomyelia extending from T4 to T10. During surgery, it was determined that the tumor located at the T11-L1 vertebral level was intramedullary, whereas the tumor situated at the L3 level exhibited an extramedullary intradural configuration. Pathological examination conclusively identified both the intramedullary and extramedullary tumors as schwannomas. Although intramedullary schwannomas at the conus medullaris are very rare, schwannoma remains a diagnosis that cannot be ignored when facing patients with intramedullary tumors with syringomyelia. Intramedullary schwannoma can have a good neurological prognosis after surgical treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.